| Literature DB >> 22047211 |
Jost Steinhaeuser1, Antje Miksch, Dominik Ose, Katharina Glassen, Iris Natanzon, Joachim Szecsenyi, Katja Goetz.
Abstract
BACKGROUND: The Chronic Care Model (CCM) is an evidence-based approach to improving the structure of care for chronically ill patients with multimorbidity. The Assessment of Chronic Illness Care (ACIC), an instrument commonly used in international research, includes all aspects of the CCM, but cannot be easily extended to the German context. A new instrument called the "Questionnaire of Chronic Illness Care in Primary Care" (QCPC) was developed for use in Germany for this reason. Here, we present the results of the psychometric properties and test-retest reliability of QCPC.Entities:
Mesh:
Year: 2011 PMID: 22047211 PMCID: PMC3339331 DOI: 10.1186/1472-6963-11-295
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Characteristics of study participants
| Female, n (%) | 74 (67.9) |
|---|---|
| Male, n (%) | 34 (31.2) |
| Age mean; (SD*) | 54.0 (7.5) |
| Years of practice experience mean; (SD*) | 18.56 (8.55) |
| Single-handed practice, n (%) | 57 (52.3) |
| Group practice, n (%) | 46 (42.1) |
| Inhabitants in practice area | |
| Less than 5,000, n (%) | 17 (15.6) |
| 5,000 to 20,000, n (%) | 36 (33.0) |
| > 20,000 to 100,000, n (%) | 20 (18.3) |
| More than 100,000, n (%) | 36 (33.0) |
* Standard deviation
Decision support and delivery system design subscale results
| Use of evidence-based guidelines by patients with:* | T0 (n = 109) | Tx1 (n = 85) | Tx2 (n = 85) | Test-retest reliability: Spearman rho | ||
|---|---|---|---|---|---|---|
| Single diseases | 2.39 (0.71) | 2.43 (0.72) | 2.39 (0.76) | 0.60 | 0.58 | < 0.01 |
| Multiple diseases | 2.50 (0.76) | 2.50 (0.77) | 2.42 (0.80) | 0.21 | 0.63 | < 0.01 |
| Differential diagnostic/therapeutic reasons | 4.03 (1.01) | 3.99 (1.00) | 3.79 (1.02) | 0.09 | 0.53 | < 0.01 |
| Own feeling of uncertainty | 2.11 (0.57) | 2.12 (0.62) | 2.15 (0.59) | 0.73 | 0.57 | < 0.01 |
| Request of a specialist | 2.07 (0.94) | 2.04 (0.94) | 2.16 (0.84) | 0.13 | 0.62 | < 0.01 |
| Disease management programs or | 2.23 (0.92) | 2.22 (0.90) | 2.30 (0.95) | 0.52 | 0.48 | < 0.01 |
| Patient request | 2.79 (0.88) | 2.84 (0.91) | 2.78 (0.93) | 0.49 | 0.62 | < 0.01 |
| Request by patient's family member | 1.95 (0.64) | 1.95 (0.65) | 1.94 (0.67) | 1.00 | 0.58 | < 0.01 |
| Do you know when your patients are being treated or admitted to hospital? * | 2.12 (0.60) | 2.11 (0.64) | 2.25 (0.62) | 0.03 | 0.52 | < 0.01 |
| How often does the provisional discharge letter provide all relevant information needed for continued care?* | 2.24 (0.61) | 2.24 (0.65) | 2.24 (0.55) | 1.00 | 0.67 | < 0.01 |
* Five-point scale ranging from 1 "always" to 5 "never"
** Five point scale ranging from 1 "0%" to 5 "more than 75%"
a Statistical significance of differences: P ≤ 0.05; b Statistical significance of differences: P ≤ 0.01
Tx1, Tx2, measurement points for re-test
Self-management support
| Items* | T0 (n = 109) | Tx1 (n = 87) | Tx2 (n = 87) | Test-retest reliability: Spearman rho | ||
|---|---|---|---|---|---|---|
| Handout of non individualized information sheets dealing with the disease on a daily basis and in difficult conditions | 3.23 (0.94) | 3.25 (0.95) | 3.21 (0.89) | 0.66 | 0.51 | < 0.01 |
| Handout of an individualized treatment plan with information on how to deal with the disease on an every day basis and in difficult conditions | 2.91 (1.12) | 3.09 (1.10) | 2.96 (1.04) | 0.26 | 0.54 | < 0.01 |
| Discussion of care/therapy options with the patients to achieve an agreed therapy concept | 1.69 (0.63) | 1.71 (0.65) | 1.79 (0.67) | 0.23 | 0.56 | < 0.01 |
| Assessment of drug history including OTC and prescription drugs from other physicians | 1.49 (0.67) | 1.49 (0.70) | 1.64 (0.67) | 0.02 | 0.63 | < 0.01 |
| Usage of specific instruments to calculate individual risks, e.g., for coronary heart disease | 3.62 (1.07) | 3.67 (1.04) | 3.67 (1.04) | 0.89 | 0.62 | < 0.01 |
| Handout of a patient-booklets for documentation, e.g., of blood glucose or pain levels | 2.26 (0.85) | 2.38 (0.85) | 2.35 (0.91) | 0.78 | 0.65 | < 0.01 |
| Handout of guideline information | 3.19 (1.02) | 3.24 (1.04) | 3.11 (0.90) | 0.16 | 0.67 | < 0.01 |
| Involvement of patient family members, if desired | 1.75 (0.77) | 1.80 (0.80) | 1.86 (0.80) | 0.48 | 0.50 | < 0.01 |
* Five-point scale ranging from 1 "always" to 5 "never"
a Statistical significance of differences: P ≤ 0.05; b Statistical significance of differences: P ≤ 0.01
Clinical information systems
| Items* | T0 (n = 109) | Tx1 (n = 85) | Tx2 (n = 85) | Test-retest reliability: Spearman rho | ||
|---|---|---|---|---|---|---|
| Access to internet | 1.23 (0.42) | 1.26 (0.44) | 1.25 (0.43) | 0.66 | 0.85 | < 0.01 |
| E-mail contact with colleagues | 1.33 (0.47) | 1.34 (0.48) | 1.37 (0.49) | 0.48 | 0.77 | < 0.01 |
| E-mail contact with patients | 1.56 (0.50) | 1.60 (0.49) | 1.56 (0.50) | 0.32 | 0.76 | < 0.01 |
| Access to medical literature | 1.07 (0.25) | 1.08 (0.28) | 1.08 (0.28) | 1.00 | 0.58 | < 0.01 |
| Access to guidelines | 1.10 (0.30) | 1.12 (0.33) | 1.14 (0.35) | 0.71 | 0.65 | < 0.01 |
| Internet homepage | 1.54 (0.50) | 1.58 (0.50) | 1.56 (0.50) | 0.32 | 0.98 | < 0.01 |
| Brochure with practice information | 1.44 (0.50) | 1.41 (0.50) | 1.38 (0.52) | 0.48 | 0.81 | < 0.01 |
| Flyer for therapeutic/diagnostic options | 1.36 (0.48) | 1.27 (0.45) | 1.27 (0.45) | 1.00 | 0.66 | < 0.01 |
| Appointment scheduling | 1.47 (0.50) | 1.51 (0.50) | 1.51 (0.50) | 1.00 | 0.95 | < 0.01 |
| Documentation/patient records | 1.05 (0.21) | 1.05 (0.23) | 1.03 (0.16) | 0.32 | 0.29 | 0.01 |
| Reminders | 1.26 (0.44) | 1.25 (0.43) | 1.26 (0.44) | 0.74 | 0.70 | < 0.01 |
| Checking for interactions when prescribing drugs | 1.24 (0.43) | 1.26 (0.44) | 1.32 (0.47) | 0.32 | 0.46 | < 0.01 |
| Access to data from hospitals | 1.86 (0.37) | 1.90 (0.34) | 1.96 (0.46) | 0.44 | 0.41 | < 0.01 |
| Screening for patients | 1.19 (0.39) | 1.21 (0.41) | 1.19 (0.40) | 0.74 | 0.61 | < 0.01 |
| Patient lists with appointments | 1.37 (0.48) | 1.36 (0.48) | 1.36 (0.48) | 1.00 | 0.57 | < 0.01 |
* Two-point scale ranging from "1" (yes) to "2" (no)
a Statistical significance of differences: P ≤ 0.05; b Statistical significance of differences: P ≤ 0.01
Community linkages
| Satisfaction with the exchange of information with:* | T0 (n = 109) | Tx1 (n = 85) | Tx2 (n = 85) | Wilcoxon matched pair test, p-valuea | Test-retest reliability: Spearman rho | |
|---|---|---|---|---|---|---|
| Other GP practices | 2.35 (0.94) | 2.39 (0.98) | 2.20 (0.95) | 0.04 | 0.62 | < 0.01 |
| Specialist practices | 2.31 (0.77) | 2.35 (0.84) | 2.33 (0.72) | 0.75 | 0.62 | < 0.01 |
| Psychotherapists | 3.13 (0.95) | 3.02 (0.98) | 3.09 (1.03) | 0.67 | 0.60 | < 0.01 |
| Physiotherapists/occupational therapists | 2.95 (0.83) | 2.59 (0.82) | 2.67 (0.89) | 0.32 | 0.52 | < 0.01 |
| Nursing homes | 2.46 (0.86) | 2.50 (0.89) | 2.60 (0.95) | 0.31 | 0.55 | < 0.01 |
| Medical supply stores | 2.80 (0.87) | 2.77 (0.85) | 2.83 (0.89) | 0.47 | 0.62 | < 0.01 |
| Pharmacies | 2.14 (0.95) | 2.09 (0.92) | 2.13 (0.97) | 0.75 | 0.59 | < 0.01 |
| Hospitals | 2.50 (0.85) | 2.50 (0.81) | 2.57 (0.77) | 0.35 | 0.58 | < 0.01 |
| Rehabilitation facilities | 2.57 (0.86) | 2.56 (0.83) | 2.55 (0.83) | 0.87 | 0.50 | < 0.01 |
* Five-point scale ranging from 1 "very satisfied" to 5 "very unsatisfied"
a Statistical significance of differences: P ≤ 0.05; b Statistical significance of differences: P ≤ 0.01
Tx1, Tx2, measurement points for the re-test